Michael C Goodnough

Title: Michael C Goodnough: Innovator in Pharmaceutical Targeting

Introduction

Michael C Goodnough is a notable inventor based in Stoughton, WI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the targeting of therapeutic molecules to motor neurons. With a total of 8 patents to his name, Goodnough's work has the potential to impact the treatment of neurological disorders.

Latest Patents

Among his latest patents is a method of targeting pharmaceuticals to motor neurons. This innovative method involves synthesizing a prodrug that comprises a therapeutic molecule covalently bound to a polymeric delivery vehicle. Additionally, the prodrug is conjugated to a botulinum neurotoxin heavy chain, enhancing its effectiveness. Another significant patent is for a chimeric toxin, which combines a botulinal neurotoxin heavy chain with a non-clostridial toxin chain. This chimeric toxin is designed for pharmacological treatment of neurological disorders, showcasing Goodnough's commitment to advancing medical science.

Career Highlights

Throughout his career, Goodnough has worked with esteemed organizations such as the Wisconsin Alumni Research Foundation and Associated Synapse Biologics. His experience in these companies has allowed him to develop and refine his innovative ideas, contributing to the advancement of pharmaceutical technologies.

Collaborations

Goodnough has collaborated with notable colleagues, including Eric Arthur Johnson and Marite Bradshaw. These partnerships have likely fostered a creative environment that encourages the development of groundbreaking solutions in the field of pharmaceuticals.

Conclusion

Michael C Goodnough stands out as an influential inventor in the pharmaceutical industry. His innovative methods and collaborative efforts continue to pave the way for advancements in the treatment of neurological disorders.